Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more

Hilltop Leaf

Hilltop Leaf
Investment Date
November 2022
Investment Type

Hilltop Leaf are leaders in the exciting development of a UK produced cannabis-based product for medicinal use in humans.

With research partnerships in place with Nottingham Trent University and the James Hutton Institute, Hilltop leaf have a strong focus on pharmaceutical quality control in a remote and secure location.

Why we chose to invest in Hilltop Leaf

Targeting market share of over 10% of the UK market, Hilltop Leaf have a strong multidisciplinary management team, a home office licence for production and a secure and EU GMP designed drying, extraction and processing factory in place. As the demand for medical cannabis gains momentum, and new benefits are uncovered for it’s use, we recognised the need to support domestic production of cannabis.

Press Release:
Scotland’s first medical cannabis facility raises £2m with Traditum. Read Here

Find out more

Fill out the form below to chat with a member of our team about partnering with Traditum.

    0113 5431446
    Leeds Office
    One Park Row
    LS1 5HN

    Sign Up to Our Newsletter

    Subscribe to updates and articles from the Traditum team. You can opt out of this at any time.

    Newsletter Sign up *
    Opt in to sign up to our newsletter